Alice Cani

Targeting the PI3K/Akt/mTOR signaling pathway in B-precursor acute lymphoblastic leukemia and its therapeutic potential

Luca M. Neri, Alice Cani, Alberto M. Martelli et al. · Leukemia · 2013 · 142 citations · Full text

Medicine, Cancer Biology, Oncology +14

miR-199a-3p Modulates MTOR and PAK4 Pathways and Inhibits Tumor Growth in a Hepatocellular Carcinoma Transgenic Mouse Model

Elisa Callegari, Lucilla D’Abundo, Paola Guerriero et al. · Molecular Therapy — Nucleic Acids · 2018 · 100 citations · Full text

Life Sciences, Molecular Biology, Oncology +17

Cytotoxic activity of the novel Akt inhibitor, MK-2206, in T-cell acute lymphoblastic leukemia

Carolina Simioni, Luca M. Neri, Giovanna Tabellini et al. · Leukemia · 2012 · 87 citations · Full text

Medicine, Oncology, Pharmacology +12

Activity of the novel mTOR inhibitor Torin-2 in B-precursor acute lymphoblastic leukemia and its therapeutic potential to prevent Akt reactivation

Carolina Simioni, Alice Cani, Alberto M. Martelli et al. · Oncotarget · 2014 · 62 citations · Full text

Medicine, Oncology, Pharmacology +13

The AKT Inhibitor MK-2206 is Cytotoxic in Hepatocarcinoma Cells Displaying Hyperphosphorylated AKT-1 and Synergizes with Conventional Chemotherapy

Carolina Simioni, Alberto M. Martelli, Alice Cani et al. · Oncotarget · 2013 · 59 citations · Full text

Life Sciences, Cell Biology, Oncology +17